SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

Mannatech (MTEX) is trending amidst intense retail speculation, primarily fueled by its exceptionally low share float which the community believes could lead to a significant short squeeze. Traders are actively discussing its potential for rapid price appreciation, with some noting recent positive financial indicators and management actions as contributing factors to its anticipated breakout.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is trending with high anticipation for the January 31, 2026 PDUFA date of its needle-free Anaphylm oral epinephrine film, a key catalyst significantly de-risked by the FDA waiving an Advisory Committee meeting. The community is expressing strong conviction for approval, highlighting Anaphylm's potential to be a market-dominant, game-changing alternative for severe allergic reactions due to its convenience. Despite active debate with short sellers and market fluctuations, many investors are looking towards significant post-approval price appreciation and future growth.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending amidst a sharp pullback, primarily driven by increased CME margin requirements that triggered liquidations. A significant portion of the community views this as a buying opportunity, pointing to an impending China export ban, strong industrial demand from AI and EVs, and a perceived disparity between physical and paper silver prices. Conversely, many contend the recent surge was an unsustainable run, anticipating further volatility.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending amid a dual narrative: China's sanctions, perceived by many as validation of its strategic importance in defense, and the imminent U.S. ban on foreign-made drones. The community is actively discussing how these developments, coupled with anticipated increases in defense budgets for U.S.-made small drones and unmanned surface vessels, could position the company for significant contract awards, despite past concerns over management's communication and tangible revenue delivery.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical ($RARE) is trending due to a significant sell-off following the unexpected failure of its late-stage setrusumab trial for brittle-bone disease to meet its primary endpoint. This news has sparked a heated community debate, with many investors questioning if the steep stock decline is an overreaction given Ultragenyx's existing portfolio of four approved therapies and multiple upcoming pipeline catalysts. While some see a 'huge opportunity' for a rebound at a deep discount, others remain cautious amid the volatility typical of the biotech sector.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

Sprott Physical Silver Trust (PSLV) is trending as the community anticipates a significant silver squeeze, fueled by an impending China export ban and surging industrial demand for AI, EVs, and solar. Investors are increasingly concerned about the divergence between paper and physical silver prices, believing years of manipulation are breaking, positioning PSLV for a substantial, generational bull run as silver gains recognition as a critical global commodity.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

GLSI is trending due to a potent combination of clinical progress, robust insider confidence, and significant short squeeze potential. The company recently reported an impressive 80% recurrence rate reduction in its breast cancer trial and extended share lock-ups for directors through September 2026, signaling strong long-term conviction from management. This is fueling community discussion around an imminent squeeze given extremely high borrowing costs and limited shares available for shorting, alongside a belief in the stock's substantial undervaluation.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is currently trending, driven by discussions around its established "digital silver" narrative and core utility. The community is actively engaging with news of the LitVM airdrop and new EVM-compatible applications that enable yield generation on the Litecoin Omnichain, alongside MWEB's transparency features. This focus on long-term utility and network development is fueling optimism about its future trajectory within the crypto space.

TryHard Holdings Ltd. is a lifestyle entertainment company that operates in Japan offering a diverse range of services across the entertainment and hospitality sectors. It operates through the following business segments: Consultancy and management, Event curation, Sub-leasing and Restaurants. The Consultancy and management segment provides expert services to clubs, including operations, event management, and strategic support to enhance performance and engagement. The Event curation segment organize and produce own events, also provides a full suite of services, including event planning, construction, entertainment booking, event operation, and ticket sales. The Sub-Leasing segment acts as an intermediary between landlords and clubs. The Restaurants segment operates several restaurants. The company was founded on October 16, 2013 and is headquartered in Osaka, Japan.

TryHard Holdings Ltd.

TryHard Holdings (THH) is trending due to significant price action and high trading volume following its recent IPO, sparking community speculation about a potential short squeeze given its low float. Investors are highlighting its strong return on equity and diversified Japanese lifestyle entertainment business, though some express concerns about its long-term viability.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending amidst high anticipation for multiple regulatory catalysts, including upcoming FDA decisions for Tradipitant for motion sickness and Bysanti. The community is actively discussing recent positive Phase 2 data showing Tradipitant's efficacy in mitigating GLP-1 induced nausea, with many speculating this could unlock a massive market and lead to significant stock re-rating or a potential buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


lborn4

Logan C Born